A study of pyrazolo-benzimidazole derivatives as spleen tyrosine kinase inhibitors: an in-silico approach

被引:0
|
作者
Sonal Dubey
P. Prabitha
Sakshi Bhardwaj
Ekta Singh
机构
[1] Krupanidhi College of Pharmacy,
来源
Structural Chemistry | 2019年 / 30卷
关键词
Pyrazolo-benzimidazole; Spleen tyrosine kinase; Anticancer;
D O I
暂无
中图分类号
学科分类号
摘要
In an effort to contribute designing of improved anticancer molecules, in-silico prediction data including pharmacophore hypothesis, 3D-QSAR model, and molecular docking studies were performed on 55 compounds collected from literature. Tyrosine kinase has been used as a target enzyme as it plays a vital role in spleen cancer. The 3VF8 protein was selected for our molecular docking studies which is a crystal structure of spleen tyrosine kinase Syk catalytic domain with pyrazolylbenzimidazole inhibitor. A five-point pharmacophore was developed using 55 molecules having IC50 ranging from 13.2 to 0.83 μM. The best predictive pharmacophoric hypothesis ADRRR_2 was characterised by survival score 6.096, R2 = 0.8103, Q2 = 0.6169, F value = 20.3, RMSE = 0.45, Pearson-r = 0.4678, SD = 0.1905, and stability = 0.323 with a four-component PLS factor. In molecular docking studies, the compounds Bnz34, Bnz41, Bnz44, and Bnz45 showed interactions with MET448, LEU377, LEU307, LEU501, GLY378, LEU453, and LEU454 residues; these compounds have low-binding energies and a good in vivo activity. The pharmacophoric feature R5 is involved in hydrogen-bonding interaction whereas R7 is involved in aromatic hydrogen-bonding interactions with LEU377, GLY378, LEU501, LEU453, and LEU454 respectively. These results explained that one hydrogen acceptor, one hydrogen donor, and three aromatic rings are crucial for spleen tyrosine kinase inhibition.
引用
收藏
页码:263 / 272
页数:9
相关论文
共 50 条
  • [1] A study of pyrazolo-benzimidazole derivatives as spleen tyrosine kinase inhibitors: an in-silico approach
    Dubey, Sonal
    Prabitha, P.
    Bhardwaj, Sakshi
    Singh, Ekta
    STRUCTURAL CHEMISTRY, 2019, 30 (01) : 263 - 272
  • [2] 3-aminopyrazolopyrazine derivatives as spleen tyrosine kinase inhibitors
    Shen, Jiayi
    Li, Xiaokai
    Zhang, Zhang
    Luo, Jingfeng
    Long, Huoyou
    Tu, Zhengchao
    Zhou, Xiaoping
    Ding, Ke
    Lu, Xiaoyun
    CHEMICAL BIOLOGY & DRUG DESIGN, 2016, 88 (05) : 690 - 698
  • [3] Identification of pyrazolopyridine derivatives as novel spleen tyrosine kinase inhibitors
    Huang, Yahui
    Li, Yu
    Dong, Guoqiang
    Zhang, Wannian
    Liu, Na
    Sheng, Chunquan
    ARCHIV DER PHARMAZIE, 2018, 351 (08)
  • [4] Spleen tyrosine kinase inhibitors
    不详
    NATURE REVIEWS DRUG DISCOVERY, 2012, 11 (03) : 181 - 181
  • [5] Benzimidazole Derivatives as Kinase Inhibitors
    Garuti, Laura
    Roberti, Marinella
    Bottegoni, Giovanni
    CURRENT MEDICINAL CHEMISTRY, 2014, 21 (20) : 2284 - 2298
  • [6] In-silico study of seaweed secondary metabolites as AXL kinase inhibitors
    Nagamalla, Lavanya
    Kumar, J. V. Shanmukha
    Sanjay, Chintakindi
    Alsamhan, Ali M.
    Shaik, Mohammed Rafi
    SAUDI JOURNAL OF BIOLOGICAL SCIENCES, 2022, 29 (02) : 689 - 701
  • [7] In Silico Study, Protein Kinase Inhibition and Molecular Docking Study of Benzimidazole Derivatives
    Karthick, Kamaraj
    Abishek, Kamaraj
    Jemima, Ebenezer Angel
    BIOINFORMATICS AND BIOLOGY INSIGHTS, 2024, 18
  • [8] Unlocking potential inhibitors for Bruton's tyrosine kinase through in-silico drug repurposing strategies
    Mohammed Alrouji
    Lizy Sonia Benjamin
    Fahad A. Alhumaydhi
    Waleed Al Abdulmonem
    Saleh Salem Baeesa
    Mohd Rehan
    Moyad Shahwan
    Anas Shamsi
    Atiya Akhtar
    Scientific Reports, 13
  • [9] Unlocking potential inhibitors for Bruton's tyrosine kinase through in-silico drug repurposing strategies
    Alrouji, Mohammed
    Benjamin, Lizy Sonia
    Alhumaydhi, Fahad A.
    Al Abdulmonem, Waleed
    Baeesa, Saleh Salem
    Rehan, Mohd
    Shahwan, Moyad
    Shamsi, Anas
    Akhtar, Atiya
    SCIENTIFIC REPORTS, 2023, 13 (01)
  • [10] In-silico STUDY OF ANTHRAQUINONE DERIVATIVES AS PROBABLE INHIBITORS OF COVID-19
    Shupeniuk, Vasyl, I
    Nepolraj, Amaladoss
    Taras, Tatiana N.
    Sabadakh, Oksana P.
    Matkivskyi, Mykola P.
    Luchkevych, Yevhen R.
    JOURNAL OF CHEMISTRY AND TECHNOLOGIES, 2022, 30 (02): : 151 - 158